Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

Oncogene

Volumn 19, Issue 31, 2000, Pages 3521-3528

  Wang, Wen Lan ^a   Healy, Mary Ellen ^a   Sattler, Martin ^a   Verma, Shalini ^a   Lin, Jeffrey ^a   Maulik, Gautam ^a   Stiles, Charles D ^a   Griffin, James D ^a   Johnson, Bruce E ^a   Salgia, Ravi ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

c Kit and stem cell factor; Cell motility; Signal transduction in lung cancer; Small cell lung cancer; STI 571

Indexed keywords

IMATINIB; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL MOTILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MICROSCOPY; PRIORITY JOURNAL; VIDEORECORDING;

EID: 0034691761     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203698     Document Type: Article

References (23)

1. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ and Lydon NB. (1996). Cancer Res., 56, 100-104.
2. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG and Druker BJ. (1997). Blood, 90, 4947-4952.
3. Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cutlilta F, Johnson BE and Mulshine JL. (1999). Clin. Cancer Res., 5, 3385-3393.
4. Chute JP, Chen T, Feigal E, Simon R and Johnson BE. (1999). J. Clin. Oncol., 17, 1794-1801.
5. DiPaola RS, Kuczynski WI, Onodera K, Ratajczak MZ, Hijiya N, Moore J and Gewirtz AM. (1997). Cancer Gene Ther., 4, 176-182.
6. Druker BJ and Lydon NB. (2000). J. Clin. Invest., 105, 3-7.
7. Druker BJ, Talpaz M, Resta D, Peng B, Buchdunger E, Ford J and Sawyers C. (1999). Blood. 94, 368a.
8. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J and Lydon NB. (1996). Nat. Med., 2, 561-566.
9. Ferry D, Hammond L, Runson M, Kris M, Miller V, Murray P, Tullo A, Feyereislova A, Averbuch S and Rowinsky E. (2000). Proc. ASCO., 19, 3a.
10. Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y and Takagi H. (1991). Oncogcne, 6, 2291-2296.
11. Johnson BE and Kelley MJ. (1995). Lung Cancer, 12, S5-S16.
12. Krystal GW, Hines SJ and Organ CP. (1996). Cancer Res., 56, 370-376.
13. Plummer HD, Catlett J, Leftwich J, Armstrong B, Carlson P, Huff T and Krystal G. (1993). Cancer Res., 53, 4337-4342.
14. Salgia R, Li JL, Ewaniuk DS, Pear W, Pisick E, Burky SA, Ernst T, Sattler M, Chen LB and Griffin JD. (1997). J. Clin. Invest., 100, 46-57.
15. Salgia R, Li JL, Ewaniuk DS, Wang YB, Sattler M, Chen WC, Richards W, Pisick E, Shapiro GI, Rollins BJ, Chen LB, Griffin JD and Sugarhaker DJ. (1999a). Oncogene, 18, 67-77.
16. Salgia R, Li JL, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T, Tantravahi R, Chen LB and Griffin JD. (1995). J. Biol. Chem., 270, 5039-5047.
17. Salgia R, Lin J, Narsimhan R, Chen W, Mach N, Dranoff G, Sattler M and Griffin J. (1998). Blood, 92, 487a.
18. Salgia R. Quackenbush E, Lin J, Souchkova N, Sattler M, Ewaniuk DS, Klucher KM, Daley GQ. Kraeft SK, Sackstein R, Alyea EP, von Andrian UH, Chen LB, Gutierrez-Ramos JC, Pendergast AM and Griffin JD. (1999b). Blood, 94, 4233-4246.
19. Sattler M and Salgia R. (1997). Cytokine Growth Factor Rev., 8, 63-79.
20. Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV and Griffin JD. (1997). J. Biol. Chem., 272, 10248-10253.
21. Sattler M, Verma S, Byrnc CH, Shrikhande G, Winkler T, Algate PA, Rohrschneider LR and Griffin JD. (1999a). Mol. Cell. Biol., 19, 7473-7480.
22. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R and Griffin JD. (1999b). Blood, 93, 2928-2935.
23. Sawyers CL and Druker B. (1999). Cancer. J. Sci. Am., 5, 63-69.